Dr. Genevieve Legault, MD
Claim this profileMontreal Children's Hospital
Studies Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
8 reported clinical trials
12 drugs studied
Area of expertise
1Brain Tumor
NTRK positive
IDH positive
H3 K27 positive
2Diffuse Intrinsic Pontine Glioma
NTRK positive
IDH positive
H3 K27 positive
Affiliated Hospitals
Clinical Trials Genevieve Legault, MD is currently running
Ribociclib + Everolimus
for Brain Tumors
This trial is testing whether the combination of ribociclib and everolimus can help children and young adults with aggressive brain tumors live longer. Everolimus is a medication that has been approved for treating various cancers. These drugs are taken by mouth and work by stopping cancer cells from growing. The study focuses on patients whose tumors have specific genetic changes that make them hard to treat with standard therapies.
Recruiting1 award Phase 2
ACTEMRA
for Pediatric Craniopharyngioma
This trial tests ACTEMRA, a drug that blocks a protein called IL-6, in children with a recurring brain tumor called ACP. The goal is to see if it can reduce tumor growth and improve their quality of life.
Recruiting1 award Phase 235 criteria
More about Genevieve Legault, MD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Genevieve Legault, MD has experience with
- Temozolomide
- Olutasidenib
- Trametinib
- Larotrectinib Surgical
- Larotrectinib
- Binimetinib
Breakdown of trials Genevieve Legault, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Protoplasmic Astrocytoma
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Genevieve Legault, MD specialize in?
Genevieve Legault, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved NTRK positive patients, or patients who are IDH positive.
Is Genevieve Legault, MD currently recruiting for clinical trials?
Yes, Genevieve Legault, MD is currently recruiting for 6 clinical trials in Montréal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Genevieve Legault, MD has studied deeply?
Yes, Genevieve Legault, MD has studied treatments such as Temozolomide, Olutasidenib, Trametinib.
What is the best way to schedule an appointment with Genevieve Legault, MD?
Apply for one of the trials that Genevieve Legault, MD is conducting.
What is the office address of Genevieve Legault, MD?
The office of Genevieve Legault, MD is located at: Montreal Children's Hospital, Montréal, Quebec H4A3J1 Canada. This is the address for their practice at the Montreal Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.